Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total Bond Market
BND
|
+$1.02B |
| 2 |
Canadian Natural Resources
CNQ
|
+$958M |
| 3 |
iShares Core US Aggregate Bond ETF
AGG
|
+$896M |
| 4 |
Vanguard S&P 500 ETF
VOO
|
+$861M |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$756M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.62B |
| 2 |
Amgen
AMGN
|
+$1.68B |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$1.18B |
| 4 |
Visa
V
|
+$1.05B |
| 5 |
Invesco QQQ Trust
QQQ
|
+$1B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.79% |
| 2 | Healthcare | 9.32% |
| 3 | Financials | 8.97% |
| 4 | Consumer Discretionary | 7.33% |
| 5 | Industrials | 5.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2526
PUT
eBay
EBAY
$50.2B
| $10.4M | ﹤0.01% |
250,000
-718,200
| -74% | -$29.7M |
|
2527
State Street SPDR Nuveen ICE Municipal Bond ETF
TFI
$3.14B
| $10.4M | ﹤0.01% |
227,125
+206,349
| +993% | +$9.27M |
|
|
BCPC
2528
Balchem Corp
BCPC
$5.73B
| $10.4M | ﹤0.01% |
84,769
+407
| +0.5% | +$53.7K |
|
2529
BridgeBio Pharma
BBIO
$16.1B
| $10.3M | ﹤0.01% |
1,355,296
+145,086
| +12% | +$1.39M |
|
2530
ThredUp
TDUP
$427M
| $10.3M | ﹤0.01% |
7,871,047
+59,043
| +0.8% | +$81K |
|
2531
Legend Biotech
LEGN
$3.95B
| $10.3M | ﹤0.01% |
206,403
-350,255
| -63% | -$17M |
|
2532
CALL
Lam Research
LRCX
$386B
| $10.3M | ﹤0.01% |
245,000
+134,000
| +121% | +$5.61M |
|
2533
Delek Logistics
DKL
$3.06B
| $10.3M | ﹤0.01% |
226,924
-28,116
| -11% | -$1.44M |
|
|
PRFT
2534
DELISTED
Perficient Inc
PRFT
| $10.3M | ﹤0.01% |
146,968
-126,471
| -46% | -$8.72M |
|
2535
Sturm, Ruger & Co
RGR
$596M
| $10.2M | ﹤0.01% |
202,235
+67,021
| +50% | +$3.64M |
|
2536
Melco Resorts & Entertainment
MLCO
$2.14B
| $10.2M | ﹤0.01% |
890,018
-580,007
| -39% | -$4.71M |
|
2537
Hamilton Lane
HLNE
$5.51B
| $10.2M | ﹤0.01% |
160,212
+51,407
| +47% | +$3.42M |
|
2538
Organon & Co
OGN
$3.56B
| $10.2M | ﹤0.01% |
365,188
-231,313
| -39% | -$5.91M |
|
2539
Grupo Cibest SA
CIB
$21B
| $10.2M | ﹤0.01% |
357,245
+329,615
| +1,193% | +$8.52M |
|
|
AKRO
2540
DELISTED
Akero Therapeutics
AKRO
| $10.2M | ﹤0.01% |
185,912
-1,932,885
| -91% | -$82.8M |
|
2541
Sigma Lithium
SGML
$1.27B
| $10.2M | ﹤0.01% |
360,911
+289,744
| +407% | +$9.31M |
|
2542
Preferred Bank
PFBC
$1.25B
| $10.2M | ﹤0.01% |
136,407
-7,687
| -5% | -$560K |
|
2543
Allogene Therapeutics
ALLO
$680M
| $10.2M | ﹤0.01% |
1,618,125
-781,458
| -33% | -$7.23M |
|
2544
Bio-Rad Laboratories Class A
BIO
$9.27B
| $10.2M | ﹤0.01% |
24,189
-21,560
| -47% | -$8.7M |
|
2545
Strategy Inc
MSTR
$38.5B
| $10.1M | ﹤0.01% |
716,470
+2,550
| +0.4% | +$52.1K |
|
2546
monday.com
MNDY
$3.91B
| $10.1M | ﹤0.01% |
83,071
+73,623
| +779% | +$7.66M |
|
|
SIX
2547
DELISTED
Six Flags Entertainment Corp.
SIX
| $10.1M | ﹤0.01% |
434,891
-176,268
| -29% | -$3.79M |
|
2548
Agilon Health
AGL
$1.61B
| $10.1M | ﹤0.01% |
25,039
-3,009
| -11% | -$1.41M |
|
2549
Moelis & Co
MC
$4.96B
| $10.1M | ﹤0.01% |
263,184
+47,515
| +22% | +$1.93M |
|
2550
OneSpaWorld
OSW
$2.68B
| $10.1M | ﹤0.01% |
1,082,245
-250,375
| -19% | -$2.37M |
|
Similar funds
Goldman Sachs's Q4 2022 Portfolio in Review
As of Q4 2022, Goldman Sachs held 6,669 positions worth $408B, up 3.1% from $396B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Goldman Sachs withdrew a net $13.2B in Q4 2022, closing 721 positions and reducing 2,588 holdings. Its most notable exit was ChemoCentryx, Inc., an estimated $290M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Goldman Sachs opened a new position in Perfect Corp worth $104M.
- Goldman Sachs's largest Q4 2022 buy was Perfect Corp: 14,518,235 shares worth $104M.
- Goldman Sachs added most to Vanguard Total Bond Market in Q4 2022, an estimated $1.02B increase.
- Goldman Sachs's biggest Q4 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.62B.
- Goldman Sachs fully exited ChemoCentryx, Inc. in Q4 2022, selling an estimated $290M.
- Goldman Sachs's ten largest holdings make up 15% of its $408B portfolio in Q4 2022.
- Goldman Sachs opened 429 new positions and closed 721 in Q4 2022.
- Goldman Sachs's portfolio value rose 3.1% quarter-over-quarter to $408B.
Based on Goldman Sachs's 13F filing for Q4 2022, filed 13 Feb 2023.